Related references
Note: Only part of the references are listed.Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity
Xinghua Pang et al.
MABS (2023)
Adalimumab for Sintilimab-Induced Toxic Epidermal Necrolysis in a Patient with Metastatic Gastric Malignancy: A Case Report and Literature Review
Li Zhang et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2023)
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
Samuel Chuah et al.
JOURNAL OF HEPATOLOGY (2022)
Cadonilimab: First Approval
Susan J. Keam
DRUGS (2022)
Phase 2 study of AK104 (PD-1/CTLA-4 bispecific antibody) plus lenvatinib as first-line treatment of unresectable hepatocellular carcinoma.
Li Bai et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database
Jianhong Zhu et al.
ECLINICALMEDICINE (2021)
Immune checkpoint inhibitor-related dermatologic adverse events
Amaris N. Geisler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Elisabeth Perez-Ruiz et al.
NATURE (2019)
Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma
Briana Choi et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Diverse expression of TNF-alpha and CCL27 in serum and blister of Stevens-Johnson syndrome/toxic epidermal necrolysis
Fang Wang et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2018)
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
Florie Bertrand et al.
NATURE COMMUNICATIONS (2017)
SCORTEN: A severity-of-illness score for toxic epidermal necrolysis
S Bastuji-Garin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)